In the present study, 2-phenyl-1-ethanamine (phenethyl amine; 1) was reacted with 4-acetamidobenzenesulfonyl chloride (2) in the presence of 10% aqueous Na 2 CO 3 to achieve N-{4- [(phenethylamino)sulfonyl] N-(4-{[(4-chlorobenzyl) 
INTRODUCTION
Sulfonamide drugs are the pioneer of all the antibacterial drugs in pharmaceutical industry. In start of the 20 th century Trypanosomias, a disease common in mice was very progressive which was treated with certain dyes called as azo dyes. These azo dyes were then coined the name of a term "prontosil" by a scientist Bayer AG (1) . Later on, Gerhard
Domagk studied the effectiveness of prontosil against a streptococcal infection and 
aureus, and Bacillus subtilis) and Gram negative bacteria (Escherichia coli) (2).
Antimicrobial agents are successful in controlling the infectious disease caused by different pathogens (3) . Sulfonamides hydroxamic and anilides inhibits the histone deacetylase and acts as anti-tumor agents (3) . Benzimidazole derivatives of sulfonamides act as potential anticancer agents to inhibit the growth of malignant tumors (2) . Cystein protease is involved in the protein degradation, cell apoptosis. Sulfonamides interfere with the cascade reaction of caspass thus inhibiting the synthesis of protease enzyme (4) . Sulfonamides also possess strong activity against HIV proteases. HIV protease is used in combination with transcriptase inhibitors to give Highly Active Antiretroviral Therapy (HART) (4). Carbonic anhydrase are class of enzymes that is responsible for the interconversion of carbon dioxide and bicarbonate. Carbonic anhydrase causes cancer by causing hypoxia thus leading to metastatic spread of cancer cells. Sulfonamides show inhibitory activity against some carbonic anhydrases (5). Cyclooxygenase is involved in the synthesis of prostaglandins.
Sulfonamides help in curing the side effects caused by COX-II enzyme. Sulfonamides act as antioxidant (6) , and antifungal agents against strains of Aspergillus niger, Fusarium oxysporum, and Candida albicans (7) . Sulfonamides in combination with trimethoprim
show great anti-malarial activity (8) .
The literature survey has shown that the variation in structure of a molecule affects the biological activity (9-11) which prompted us to synthesize various N-substituted sulfonamides using phenethylamine as precursor. Moreover, the synthesized molecules were screened against different bacterial strains and lipoxygenase enzyme to ascertain their therapeutic potential.
EXPERIMENTAL

Measurements
Required chemicals were purchased from Sigma Aldrich. Solvents used in this study were of analytical grades. Thin layer chromatography (TLC) was carried out on pre-coated silica gel G-25-UV 254 plates by using ethyl acetate and n-hexane as mobile phase. Melting points of the synthesized compounds were recorded on a Griffin and George melting point apparatus by open capillary tube and were uncorrected. IR spectra were recorded in KBr pellet method on a Jasco-320-A spectrometer (wave number in cm -1 ). 1 H-NMR spectra were taken in CDCl 3 through the Bruker spectrometer operating at 400 MHz. Mass spectra (EIMS) was recorded on a JMS-HX-110 spectrometer, with a data system.
Synthesis of N-{4-[(Phenethylamino)sulfonyl]phenyl}acetamide (3)
2-phenyl-1-ethanamine (phenethyl amine; 1.0 mmol; 1) in 100 mL water was dispersed in a round bottom flask and pH was maintained at 9-10 by (10%) aqueous 
Synthesis of N-(4-{[(Alkyl
Antibacterial Assay
The antibacterial activity was evaluated by using the referenced method but with minor modifications (12) (13) (14) . The change in absorbance was observed after 6 min at 234 nm. All reactions were performed in triplicates. The positive and negative controls were included in the assay.
Quercetin (0.5 mM well -1 ) was used as a positive control.
IC 50 values (concentration at which there is 50 % enzyme inhibition) of compounds was calculated using EZ-Fit Enzyme kinetics software (Perella Scientific Inc. Amherst, USA).
Statistical Analysis
All the measurements were done in triplicate and statistical analysis was performed by Microsoft Excel 2010. Results are presented as mean ± SEM.
RESULTS AND DISCUSSION
The targeted derivatives of N-{4-[(phenethylamino)sulfonyl]phenyl}acetamide (3)
were synthesized by the protocol given in Scheme 1, Table 1 . The reaction conditions are discussed in the experimental section. The structures of all the synthesized compounds were confirmed by spectral analysis using IR, 1 H-NMR and EI-MS techniques. The synthesized compounds were screened for their antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi, Bacillus subtilis and Staphylococcus aureus ( Table 2 and Table 3 ) as well as for anti-enzymatic activity against lipoxygenase enzyme ( Table 4) . 
Pharmacological screening
Antibacterial Activity
Synthesized derivatives were screened for their antibacterial activity against three respectively, relative to ciprofloxacin (MIC; 7.22±0.67 µg mL -1 ). This activity might probably be due to substitution of butan-2-yl group in 5e on parent skeleton of molecule 3.
However, the parent molecule, 3, itself portrayed good activity against S. aureus.
Compound 5e also displayed very good activity against P. aeruginosa with MIC value of 10.46±0.95 µg mL -1 . However, compounds 5c and 5d remained totally inactive against all the bacterial strains used in the present study. The results are tabulated in Table 2 and Table 3. 3, 5b, 5e and 5f showed very low activity at the same concentration. The percentage inhibition values ranged from 29.29±0.78 to 38.61±0.92%. 
CONCLUSION
The structures of N-(4-{[(Alkyl/aralkyl)(phenethyl)amino]sulfonyl}phenyl)
acetamides were well-supported by spectroscopic data. Antibacterial potential of the parent sulfonamide 3 and its derivatives, 5a-f, revealed that they were exhibiting moderate to good antibacterial potential against all the bacterial strains, except 5c and 5d which remained sheer inactive. However, against lipoxygenase enzyme, 5c was the sole candidate which showed reasonable inhibition, while all remaining compounds rendered weaker inhibition. On the basis of aforesaid results, the synthesized acetamide derivatives provide an overall indispensable basis to introduce new drug candidates for the cure of inflammatory and other associated diseases.
